“Remdesivir for COVID-19” Study accidentally proved effectiveness of Hydroxychloroquine

The use of Remdesivir for COVID-19 was authorized by the FDA based on a single RCT, conducted by NIAID with the participation of Gilead Sciences, the exclusive manufacturer of Remdesivir.…

SARS-CoV2 and the Rise of Medical Technocracy. Lee Merritt, M.D.

From DDP 38th Annual Meeting, August 16, 2020, Las Vegas, NV

COVID-19: Is there an opportunity in the crisis? Jane M. Orient, M.D.

DDP 38th Annual Meeting August 16, 2020, Las Vegas, NV

Hypothesis: Restrictions on Hydroxychloroquine Contribute to the COVID-19 Cases Surge

Although Hydroxychloroquine remains an approved drug and doctors can still prescribe it off-label, the FDA’s and NIH’s opinions have significant influence. State governments and medical boards adhere to the FDA…

Lancet, New England Journal retract Covid-19 studies, including one that raised safety concerns about malaria drugs

From Stat By Andrew Joseph @DrewQJoseph June 4, 2020Reprints The Lancet, one of the world’s top medical journals, on Thursday retracted an influential study that raised alarms about the safety…

Nevermind…Maybe HCQ not so bad.

As noted previously by Leo Goldstein, there has been a coordinated attempt by institutional press and academia to discredit the use of Hydroxychloroquine. https://wattsupwiththat.com/2020/05/11/distributed-denial-of-hcq-to-covid-19-victims/ As noted in yesterday’s edition of…

Brazilian scientists and academics write an Open Letter on the “science” of the #coronavirus pandemic

From CONEXÃPOLÍTICA The coordinator of the statement is Marcos Nogueira Eberlin. He is a member of the Brazilian Academy of Sciences and holds a PhD in chemistry from the University…